EXECUTIVE ENGAGEMENTS
POOL
5667
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
907
Interactions with Platform & by Email
PARTICIPANTS
172
Unique # Participated
VALIDATIONS
37
Responses Validated*
COMPANIES
39
Responses Validated*
* Login for a full stack data experience
DATE
OCT 2022
TABLES
202
PAGES
272
EDITION
16
PRICE
USD 5450
CODE
MCP-1632
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
What`s New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Amid the COVID-19 crisis, the global market for Cardiac Biomarkers estimated at US$9.5 Billion in the year 2020, is projected to reach a revised size of US$15.7 Billion by 2027, growing at a CAGR of 7.5% over the analysis period 2020-2027. Troponins (T & I), one of the segments analyzed in the report, is projected to record a 8.9% CAGR and reach US$6.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Brain Natriuretic Peptide (BNPs) or NT-proBNP segment is readjusted to a revised 7.1% CAGR for the next 7-year period.
The Cardiac Biomarkers market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.7 Billion by the year 2027 trailing a CAGR of 12.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
In the global Myocardial Muscle Creatine Kinase (CK-MB) segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.2 Billion by the year 2027, while Latin America will expand at a 7.9% CAGR through the analysis period.
SELECT PLAYERS
Abbott Diagnostics; Beckman Coulter Inc.; BG Medicine; bioMérieux SA; Boditech Med Inc.; Labsystems Diagnostics OY; LifeSign LLC; LSI Medience Corp.; Merck KGaA; Ortho-Clinical Diagnostics Inc.; Quidel Corporation; Randox Laboratories; Response Biomedical Corp.; Roche Diagnostics Corp.; Siemens Healthineers
SEGMENTS
» Product (Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA), Other Products) » Location Type (Laboratory Testing, Point-of-Care Testing)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| A Curtain Raiser |
| Major Cardiac Markers and their Properties |
| Recent Market Activity |
| Market Set to Record Strong Growth Led by Advancements in Cardiac Biomarker Combinations |
| North America Corners Biggest Slice, Asia-Pacific to Dictate Market Momentum |
| Laboratory Testing Remains Gold Standard, POC Testing Rapidly Gains Traction |
| Analysis by Type of Cardiac Biomarker Assay/Test |
| Competitive Landscape |
| Intense Competition among Players in the Cardiac Diagnostics Market |
| Leading Vendors Focus on Curtailing Turnaround Time of POC Cardiac Testing Kits |
| Cardiac Markers Point-Of-Care Testing (POC) Cardiac Testing Segment: Major Players and their Operating Brands |
| Other Recent Innovations |
| Lipid Biomarker Panel to Detect HfrEF |
| VectraplexECG System with CEB® Cardiac Electrical Biomarker |
| Cardiac Biomarkers on Smartphone |
| Stringent Regulations and Other Challenges |
| Cardiac Biomarkers – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Diagnostics, Inc. (USA) |
| Quidel Corporation (USA) |
| Beckman Coulter, Inc. (USA) |
| BG Medicine, Inc. (USA) |
| biomérieux SA (France) |
| Boditech Med Inc. (South Korea) |
| Labsystems Diagnostics OY (Finland) |
| LifeSign LLC (USA) |
| LSI Medience Corporation (Japan) |
| Ortho-Clinical Diagnostics, Inc. (USA) |
| Randox Laboratories Ltd. (UK) |
| Response Biomedical Corp. (Canada) |
| Roche Diagnostics (Switzerland) |
| Siemens Healthineers (USA) |
| Merck KGaA (Germany) |
| 3. MARKET TRENDS & DRIVERS |
| The Grim Reality of Mounting Economic and Social Burden of Cardiovascular Disease |
| Population Explosion, Ballooning Geriatric Populace, Longer Life Expectancy Contributing to Rising Tide of CVDs |
| Cardiac Biomarkers Hold the Key to Timely, Accurate Diagnosis & Prognosis |
| Commercialization of Novel Biomarkers to Drive Market Growth |
| Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers |
| Cardiac Biomarkers - A Powerful Tool for Patient Triaging |
| Cardiac Biomarkers Market Transitions from Mono-Marker to Multi-Marker Assays |
| Government Support Instrumental for Boosting Market Momentum |
| Secretoneurin Biomarker - a Potential Game Changer for Diagnosis of Cardiac Arrhythmias |
| High-Performance Techniques Drive Biomarker Discovery in Cardiology |
| Biomarkers for Acute Coronary Syndromes (ACS): A Leading Segment |
| Biomarkers - A Promising Diagnostic Tool for ACS |
| Biomarker Discovery for ACS to Undergo Significant Changes |
| Cardiac Biomarker Play Critical Role in Stroke Diagnosis |
| Cardiac Biomarkers to Find a Place in Neonatal Diagnosis and Treatment |
| Specificity, Sensitivity, Side Effects, Cost Concerns Hinder Market Growth |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Laboratory Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Point-of-Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Point-of-Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Point-of-Care Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Troponins (T & I) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Troponins (T & I) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Troponins (T & I) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Brain Natriuretic Peptide (BNPs) or NT-proBNP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Brain Natriuretic Peptide (BNPs) or NT-proBNP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Brain Natriuretic Peptide (BNPs) or NT-proBNP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Myocardial Muscle Creatine Kinase (CK-MB) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Myocardial Muscle Creatine Kinase (CK-MB) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Myocardial Muscle Creatine Kinase (CK-MB) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Ischemia-Modified Albumin (IMA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ischemia-Modified Albumin (IMA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ischemia-Modified Albumin (IMA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
| World Cardiac Biomarkers Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| USA Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Canada Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| JAPAN |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Japan Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| CHINA |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| China Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| EUROPE |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cardiac Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
| Europe Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| FRANCE |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| France Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| GERMANY |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Germany Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Italy Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| UNITED KINGDOM |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| UK Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Spain Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Russia Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Rest of Europe Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| ASIA-PACIFIC |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cardiac Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
| Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| AUSTRALIA |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E) |
| Australia Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Australia Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| INDIA |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
| India Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| India Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| South Korea Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| LATIN AMERICA |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E) |
| Latin America Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Cardiac Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027 |
| Latin America Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Argentina Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Brazil Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Mexico Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| MIDDLE EAST |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
| Middle East Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for Cardiac Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Cardiac Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027 |
| Middle East Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Iran Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Israel Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| UAE Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| AFRICA |
| Cardiac Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E) |
| Africa Recent Past, Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2021 & 2027 |
| Africa Recent Past, Current & Future Analysis for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Cardiac Biomarkers by Product - Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Cardiac Biomarkers by Product - Percentage Breakdown of Value Sales for Troponins (T & I), Brain Natriuretic Peptide (BNPs) or NT-proBNP, Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Ischemia-Modified Albumin (IMA) and Other Products for the Years 2012, 2021 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com